Citation: Timothy Jan Bergmann, Giorgia Brambilla Pisoni, Maurizio Molinari. Quality control mechanisms of protein biogenesis: proteostasis dies hard[J]. AIMS Biophysics, 2016, 3(4): 456-478. doi: 10.3934/biophy.2016.4.456
[1] | Xinyou Meng, Jie Li . Stability and Hopf bifurcation analysis of a delayed phytoplankton-zooplankton model with Allee effect and linear harvesting. Mathematical Biosciences and Engineering, 2020, 17(3): 1973-2002. doi: 10.3934/mbe.2020105 |
[2] | Juan Li, Yongzhong Song, Hui Wan, Huaiping Zhu . Dynamical analysis of a toxin-producing phytoplankton-zooplankton model with refuge. Mathematical Biosciences and Engineering, 2017, 14(2): 529-557. doi: 10.3934/mbe.2017032 |
[3] | Ruiqing Shi, Jianing Ren, Cuihong Wang . Stability analysis and Hopf bifurcation of a fractional order mathematical model with time delay for nutrient-phytoplankton-zooplankton. Mathematical Biosciences and Engineering, 2020, 17(4): 3836-3868. doi: 10.3934/mbe.2020214 |
[4] | Hong Yang . Global dynamics of a diffusive phytoplankton-zooplankton model with toxic substances effect and delay. Mathematical Biosciences and Engineering, 2022, 19(7): 6712-6730. doi: 10.3934/mbe.2022316 |
[5] | Saswati Biswas, Pankaj Kumar Tiwari, Yun Kang, Samares Pal . Effects of zooplankton selectivity on phytoplankton in an ecosystem affected by free-viruses and environmental toxins. Mathematical Biosciences and Engineering, 2020, 17(2): 1272-1317. doi: 10.3934/mbe.2020065 |
[6] | Zuolin Shen, Junjie Wei . Hopf bifurcation analysis in a diffusive predator-prey system with delay and surplus killing effect. Mathematical Biosciences and Engineering, 2018, 15(3): 693-715. doi: 10.3934/mbe.2018031 |
[7] | Honghua Bin, Daifeng Duan, Junjie Wei . Bifurcation analysis of a reaction-diffusion-advection predator-prey system with delay. Mathematical Biosciences and Engineering, 2023, 20(7): 12194-12210. doi: 10.3934/mbe.2023543 |
[8] | Yong Yao . Dynamics of a delay turbidostat system with contois growth rate. Mathematical Biosciences and Engineering, 2019, 16(1): 56-77. doi: 10.3934/mbe.2019003 |
[9] | He Liu, Chuanjun Dai, Hengguo Yu, Qing Guo, Jianbing Li, Aimin Hao, Jun Kikuchi, Min Zhao . Dynamics induced by environmental stochasticity in a phytoplankton-zooplankton system with toxic phytoplankton. Mathematical Biosciences and Engineering, 2021, 18(4): 4101-4126. doi: 10.3934/mbe.2021206 |
[10] | Guangxun Sun, Binxiang Dai . Stability and bifurcation of a delayed diffusive predator-prey system with food-limited and nonlinear harvesting. Mathematical Biosciences and Engineering, 2020, 17(4): 3520-3552. doi: 10.3934/mbe.2020199 |
Abbreviations: AOP: Advanced oxidation process; Azi: Azithromycin; DP: Degradation Product; Ery: Erythromycin; ESI: Electrospray ionization; HPLC: high performance liquid chromatography; LC50: lethal concentration; MS: mass spectrometer; Q: TOF quadrupole time-of-flight; QSAR: quantitative structure-activity relationship; Spi: Spiramycin; Tyl: Tylosin; UV: Ultra violet; VUV: Vacuum ultra violet; MIC: minimal inhibitory concentration
One of the major current trends in water studies is the research towards a fourth purification stage in wastewater treatment plants (WWTP), as more and more micropollutants are detected in WWTP effluents and in various water bodies [1,2,3,4]. The use of activated carbon, ozonation and advanced oxidation processes (AOPs), such as the irradiation with UV light often in combination with photocatalysts or degradation accelerating agents, e.g. titaniumdioxide or hydrogenperoxide, are being intensely discussed. A common goal of many of these AOPs is the generation of hydroxyl radicals. These are formed by homolysis of water under vacuum UV radiation [5,6,7]. Hydroxyl radicals are highly reactive and react quickly with any organic compound in the solution. The presence of hydroxyl radicals has been previously demonstrated and was also observed under the conditions as used in the present study [8,9]. Yet, these oxidations processes are often assumed to give rise to products more toxic or ecologically toxic than the parent compound. These new products will negatively affect the environment. Many degradation products cannot be detected analytically with a reasonable effort due to their low concentrations. Using activated carbon for adsorption requires the treatment of the contaminated sorbent either by recycling or by combustion.
This study focuses on improved and more recent methods. Current findings reveal concentrations in ng L–1 ranges depending on the compounds [4]. The reliable, experimental evaluation and prediction of the toxicity of the degradation products are often a challenge, since most products are not commercially available and chemical synthesis would be too lengthy and costly. Alternative approaches to assess toxicity rely on computational methods, such as QSAR analysis [10,11]. QSAR analysis predicts a relationship between biological activity and chemical structure [12,13,14]. Thus, it can also be used to evaluate the eco-toxicity of the resulting photodegradation products. For this purpose, two different software products were applied in this study to calculate ecotoxicity. An experimental approach to access ecotoxicity is the determination of minimal inhibitory concentration (MIC) values. These two methods will be deployed in the field of ecotoxicology to selected macrolide antibiotics.
Today, macrolide antibiotics occur worldwide in water. In Germany, azithromycin was found in concentrations of 7–22 ng L–1 and erythromycin in concentrations of 4–190 ng L–1 in surface water. In Spanish surface waters, observed concentrations of spiramycin and tylosin were up to 488 ng L–1 [15,16,17]. In Mexico, azithromycin was observed in different canals with concentrations up to 211 ng L–1 [18]. The concentration of erythromycin was 7–1149 ng L–1 in river water in Ghana and up to 60 ng L–1 in Chinese surface waters [19,20,21]. The concentration of azithromycin and erythromycin in Portuguese rivers was measured by Pereira et al. [22]. The observed macrolide concentrations amounted to 39 ng L–1. In seawater, the concentration of azithromycin was found as high as 138.9 ng L–1 near China [23]. The occurrence of azithromycin in groundwater was confirmed by Boy-Roura et al. for Catalonia (Spain) to 7 ng L–1 [24]. The highest concentration of macrolides was observed in WWTP effluents, with macrolide concentrations in the feed samples being at least twice as high as the effluent samples [25,26,27,28,29,30]. Thus, a part of the macrolides can be eliminated by the conventional three stage sewage treatment plant. Yet, for a complete and sustainable removal of the macrolides, another stage is required. In this respect, azithromycin, erythromycin, spiramycin and tylosin were irradiated with UVC/VUV-light at pH 6–7. The products formed were identified using high-performance liquid chromatography coupled to electrospray ionization quadrupole time-of-flight mass spectrometry (HPLC-ESI-Q-TOF-MS) and examined with respect to their ecotoxicological potential. The gram-positive Bacillus subtilis and the gram-negative Pseudomonas fluorescens minimal inhibitory concentrations (MIC) of the four macrolides and their solutions were determined as a function of irradiation time to assess potential ecotoxicological hazards. Both bacterial strains occur ubiquitously in soil and waters, allowing the evaluation of the environmental impact [31].
Azithromycin dihydrate (Alfa Aesar, purity 98%) consisting of form A (Azi A) and B (Azi B), erythromycin free base (BioChemica AppliChem, purity 95%) consisting of form A (Ery A), B (Ery B) and F (Ery F), spiramycin (Alfa Aesar, 90%), consisting of form spiramycin I (Spi I) and spiramycin Ⅲ (Spi Ⅲ), and tylosin tartrate (Alfa Aesar, purity 95%) consisting of form A (Tyl A) and B (Tyl B) were used for photodegradation experiments. Hydrochloric acid and ammonia (approximately 25% Riedel-de Haen; pro analysis, Reag ISO, Reag Ph. Eur.) were used to adjust the pH value of the solution. Methanol (LiChrosolv Merck for liquid chromatography), MilliQ water (Simplicity 185, Merck Millipore, Billerica, MA, USA) and formic acid (Fluka, LC-MS-Grade) were used as eluent for HPLC-ESI-Q-TOF-MS experiments.
The photodegradation experiments of macrolides were carried out in a 1 L-batch reactor (Peschl Ultraviolet, Mainz, Germany) wrapped in aluminum foil to prevent penetration of irradiation. A low-pressure mercury immersion lamp (TNN 15/32, 15 W, Heraeus, Hanau, Germany), which emits polychromatic light with maximum radiation intensities at 185,254,313,365 405,437,547,578, and 580 nm, was located in the center of the batch reactor. Each of the four macrolides was dissolved separately in 800 mL MilliQ water (Simplicity 185, Merck Millipore, Billerica, MA, USA) to yield a final concentration of 20 mg L–1. The solution was irradiated in the batch reactor for 10 min. The total photon flux of the UV lamp was determined to 2 mmol min–1 L–1 by ferrioxalate actinometry [32,33]. The temperature in the reactor was kept at 22 ± 2 ℃ for all photodegradation experiments. A magnetic stirrer (500 rpm) was used for mixing. For comparison purposes, the absorption spectrum of each compound was recorded using a UV/Vis spectrophotometer (UV-1601 PC, Shimadzu, Kyoto, Japan).
Samples from photodegradation experiments were analyzed using HPLC Agilent 1200 (Agilent, Santa Clara, USA) coupled with an ESI-Q-TOF mass spectrometer Agilent 6530 (Agilent, Santa Clara, USA). The column used for chromatographic separation was a reversed-phase C-18 CoreShell column (Thermo Scientific, Dreieich, Deutschland) having dimensions of 50 mm × 2.1 mm and 2.6 μm particle size. The column temperature was kept constant at 40 ℃. Two eluents were used during the gradient-program: MilliQ water with 0.1% formic acid as eluent A and methanol with 0.1% formic acid as eluent B. The gradient steps over a total run time of 12 min were: during 1 min 1–30% B, during the next 10 min 30–75% B, till 11.1 min 75–99% B, hold 99% for 0.1 min, return to starting conditions (1% B) within 0.8 min.
The mass spectrometer was equipped with a Jet-Stream Electrospray-Ion-source (ESI), which was operated in positive detection mode. The collision gas flow was set to 8 L min–1, the gas temperature was 300 ℃ and the fragmentor voltage was 175 V. Mass spectrometer and HPLC system were controlled via MassHunter Workstation B.06.00 (Agilent, Santa Clara, USA) running under Windows 7 Professional. Chromatograms and mass spectra were processed and analyzed using the same software.
Using a syringe, samples of 2 mL volume were taken from the reactor at 30 second intervals during the first 5 min, and thereafter at 1 minute intervals. The total irradiation time was 10 min. Samples were transferred to the HPCL-ESI-Q-TOF-MS and for MIC determination.
Photolysis proceeds following first order or pseudo-first order reaction kinetics according to Equations 1 and 2, where ν is the reaction velocity, cA is the concentration of each macrolide, the index 0 denotes the starting concentration, k1 is the reaction rate constant and t the time [9,34,35,36,37]. In this work, the concentration-time (c-t) curves were determined as mass area-under-the-curve depending on irradiation time resulting from the HPCL-ESI-Q-TOF-MS experiments. They were described according to first order kinetics. The degradation products are considered intermediates and their c-t curves can be described as a consecutive and subsequent follow-up reaction [9,36]. All c-t curves were fitted mathematically using the curve fitting toolbox within the software MatLab R2016b (MathWorks, Natrick, USA).
ν=−dcAdt=k1⋅cA | (1) |
cA=cA0⋅e−k1t | (2) |
The quantum efficiencies
Φ254=k2.303⋅l⋅ε254⋅I0,254 | (3) |
The quantum efficiency at 254 nm
The minimal inhibitory concentration (MIC) assay was performed according to ISO 20776-1:2007 [38] Two bacterial strains were selected: Pseudomonas fluorescens (DSMZ-No. 50090), and Bacillus subtilis (DSMZ-No. 10). The method followed the protocol described by Wiegand, Hilpert and Hancock [39].
For QSAR analysis, the software T.E.S.T. and the software OECD QSAR Toolbox were used [40]. QSAR was calculated using the corresponding option in the software T.E.S.T. The following organisms were selected as indicators: Daphnia magna LC50 (48 h) in mg L–1 and fathead minnow LC50 (96 h) as target organisms and 'Photoinduced Toxicity on D. magna' and 'Mortality LC50 (48 h) of brachiopoda' for non-specified test organisms. These organisms represent species of the aquatic environment. The structure of each compound was sketched using ACD/ChemSketch 2016.1.1 (ACDLabs, Inc., Toronto, ON, Canada) and imported into the software T.E.S.T and QSAR toolbox.
The chemical structures of the four macrolides investigated are depicted in Table 1 together with the m/z value of their quasi-molecular ion and the major fragments observed in MS. In water, erythromycin is often found as anhydro-erythromycin [18,23,26,41,42]. This is formed from erythromycin A by elimination of a water molecule. This reaction is especially preferred in acidic solutions [9,43,44,45]. Among the other macrolides, this dehydration has not been observed. Macrolides are often unstable in an acidic environment, such that a chemical degradation may occur even before irradiation [9,44,45,46,47,48,49,50,51,52].
compound | theoretical [M+H]+ | observed [M+H]+ | fragments | structure |
Azi A | 749.5158 | 749.5258 | 591.4215; 375.2667 |
![]() |
Azi B | 733.5209 | 733.5300 | 575.4329; 367.2689 |
![]() |
Ery A | 734.4685 | 734.4732 | 576.3794; 558.3669 |
![]() |
Ery B | 718.4736 | 718.4785 | 542.3717 | ![]() |
Ery A-H2Oa | 716.4580 | 716.4619 | - | |
Ery A-H2Ob | 716.4580 | 716.4623 | - | |
SpiI | 843.5213 | 843.5269 | 438.2800; 422.2667; 781.5456 |
![]() |
SpiⅢ | 899.5475 | 899.5485 | - | ![]() |
Tyl A | 916.5264 | 916.5374 | 742.4372; 582.3637; 336.2019 |
![]() |
Tyl B | 772.4478 | 772.4559 | 598.3348; 582.3637 |
![]() |
The experimental [M+H]+ values agreed well with the theoretical values. The detected fragments all possessed the lactone ring, from which sugar moieties had already been eliminated.
Table 2 shows the first order rate constants determined from the degradation experiments using UVC irradiation. Quantum efficiencies at 254 nm according to Equation 3 are also given.
Substance | k /min–1 | t1/2 /min | Φ254 |
Azi A | 0.39 | 1.80 | 1.02 |
Azi B | 0.31 | 2.23 | 0.81 |
Ery A | 0.59 | 1.18 | 0.55 |
Ery B | 0.66 | 1.04 | 0.61 |
Ery A–H2Oa | 0.59 | 1.17 | 0.55 |
Ery A–H2Ob | 1.11 | 0.63 | 1.03 |
Spi I | 0.62 | 1.12 | 0.05 |
Spi Ⅲ | 0.64 | 1.08 | 0.05 |
Tyl A | 2.47 | 0.28 | 0.04 |
Tyl B | 1.66 | 0.42 | 0.03 |
The quantum efficiencies of azithromycin A and erythromycin A-H2Ob amounted to a value larger than 1. This can only be explained by assuming that the compound was additionally degraded by a mechanism other than photodegradation [53]. Such a mechanism was assumed degradation induced by hydroxyl radicals generated from water by UVC irradiation [5,6].
Tylosin generally degraded significantly faster than azithromycin and erythromycin. The degradation curves of azithromycin A, erythromycin A, spiramycin I, and tylosin A are shown in Figure 1. Tylosin A was degraded faster than tylosin B, since tylosin B is formed from tylosin A through elimination of the sugar moiety cladinose. The quantum efficiency of tylosin is lower by a factor of 10 than those of azithromycin and erythromycin, whereas the reaction proceeds much faster or more frequent following the reaction rates.
In general, the photodegradation of azithromycin and erythromycin is assumed to be determined by hydroxyl radicals due to the lack of chromophores that support absorption of photons and hence initiation of photoreactions. As to spiramycin and tylosin on the other hand, degradation is determined by their own photoreactivity since they have conjugated double bonds that absorb photons leading to the photoreaction [9,52].
All identified photodegradation products are shown in Table 3. Their proposed structures are shown in Figure 2.
substance | photo-degradates | Rt /min | theoretical [M+H]+ | observed [M+H]+ | fragments |
Azithromycin | 192 | 0.5 | 192.123 | 192.126 | - |
591 | 4.8 | 591.422 | 591.427 | 434.315; 296.217 |
|
434 | 5.2 | 434.312 | 434.315 | - | |
735 | 5.4 | 735.500 | 735.506 | 591.426; 368.257 |
|
592 | 8.5 | 592.406 | 592.408 | 300.278; 237.102 |
|
720 | 8.8 | 720.453 | 720.462 | 540.308; 375.266; 250.994 |
|
Erythromycin | 192 | 0.6 | 192.123 | 192.123 | - |
720 | 7.5 | 720.452 | 720.457 | 558.366; 460.414; 375.263 |
|
Spiramycin | 160 | 0.6 | 160.133 | 160.134 | 142.123 |
322 | 3.2 | 322.186 | 322,185 | 118.086 | |
336 a | 3.7 | 336.202 | 336.204 | 192.122; 174.111; 145.084; 127.074; 101.059 |
|
336 b | 4.4 | 336.202 | 336.204 | 192.122; 174.111; 145.084; 127.074; 101.059 |
|
Tylosin | 192 | 1.1 | 192.123 | 192.123 | - |
215 | 1.8 | 215.128 | 215.090 | - | |
352 | 3.7 | 352.196 | - | ||
336 | 4.2 | 336.202 | 336.201 | - |
Photodegradation products for azithromycin with m/z values of the quasi-molecular ions of 735,720,592,591 and 434 were observed and their structures identified. These seven products are consistent with the observations of Tong et al. [54]. In addition, a product with a m/z value of 192 was identified, see Figure 2.
For erythromycin, products with m/z values of the quasi-molecular ions of 750,720, and 192 were found. These products were not reported previously in the literature.
Batchu et al. identified products with m/z values of the quasi-molecular ions of 678,608,590 and 429. The occurence of these products could not be confirmed in this study, cf. Figure 1 [55] During the photodegradation of spiramycin, three products could be identified. The corresponding m/z values of the quasi-molecular ions were 160 and 336. The ion with a m/z value of 336 occurred at two different retention times in the chromatogram. The retention times were 3.8 and 4.2 min. Due to the relative similarity of the retention times, these degradates were assumed to be structurally similar products. An MSn analysis confirmed the hypothesis as the same fragments were obtained (data not shown). With regard to the detected masses and their c-t courses, the degradates represent intermediate photoproducts. The two species could be diastereoisomers, which may have been formed. The isomerism would occur at the position where the lactone ring was attached, i.e. stereoisomers with respect to a resulting hydroxyl group, which could assume R or S configuration, after sugar moiety cleavage from the lactone ring by hydroxyl radical substitution.
The degradation of tylosin under UV irradiation has also been investigated several times [56,57,58]. However, no photodegradation products were described in these studies. In this work, sugar fragments were found as degradation products. The associated m/z values were 352,336,215 and 192, see Figure 1.
Ecotoxicity was estimated through determination of the MICs against B. subtilis and Ps. fluorescens and through QSAR analysis. The results of both toxicity assessments are shown in Table 4.
compound | MIC against B. subtilis /µg mL–1 | MIC against Ps. fluorescens /µg mL–1 | Daphnia magna LC50 (48 h) mg/La | Fathead minnow LC50 (96 h) mg/La | Fathead minnow LC50 (96 h) mg/Lb, c | Branchiopoda LC50 (48 h) mg/Lb, d |
Azi A | 5.90 | 49.48 | 80.84 | 0.33 | - | 3.04 |
Azi B | 72.43 | 0.87 | - | 2.22 | ||
735 | 98.37 | 0.14 | - | 3.99 | ||
720 | 202.02 | - | - | 28.4 | ||
592 | 108.58 | 0.04 | - | 23.4 | ||
591 | 151.56 | 0.10 | - | 3.26 | ||
434 | 97.23 | 4.09 | 695 | 23.3 | ||
192 | 2067.67 | 4087.53 | 1.58E5 | 1780 | ||
Ery A | 0.21 | 96.90 | 135.5 | - | - | 8.6 |
Ery B | 127.65 | - | - | 0.98 | ||
Ery C | 193.84 | - | 340 | 11.3 | ||
Ery F | 333.08 | - | - | 68.4 | ||
716 | 129.61 | - | 193 | 6.36 | ||
192 | 2067.67 | 4087.53 | 1.58E5 | 1780 | ||
Spi I | 7.03 | 177.75 | 69.14 | - | - | 97 |
Spi Ⅲ | 15.00 | - | - | 34.2 | ||
336 | 579.58 | 410.60 | 2.69E5 | - | ||
322 | 666.63 | 547.26 | 4E5 | - | ||
160 | 367.72 | 1062.61 | 1.88E4 | - | ||
702 | 211.54 | - | - | 703 | ||
Tyl A | 1.26 | 160.80 | 104.55 | - | - | 426 |
Tyl B | 76.56 | - | - | 264 | ||
352 | 347.51 | 683.37 | 4.39E4 | - | ||
336 | 579.58 | 410.60 | 2.69E5 | - | ||
215 | 90.11 | 246.51 | 551 | - | ||
192 | 2067.67 | 4087.53 | 1.58E5 | 1780 | ||
a T.E.S.T b QSAR Toolbox c Pimephales promelas d undefined testorganisms |
For the four macrolides, high MIC values were determined on Ps. fluorescens. Growth delay was also observed. This is indicative for the lack of efficiency against Ps. fluorescens, which is in agreement with expectations, since macrolides are administered against gram-positive bacterial infections. Due to the absence of activity against Ps. fluorescens, only B. subtilis was exposed to the drugs. The cleavage of the sugar moieties of macrolides upon irradiation as described above raised the expectation of inactivity of the degradates [43,59]. The ecotoxicity estimation using MIC was hence based on B. subtilis. To this purpose, it was assumed that environmental hazard would be minimal when the solution containing the drug ceased showing antibacterial activity. Using the degradation rate constants k1 from Table 2 and the MIC value, the time tTOX can be calculated according to Equation 4. Here, tTOX is the time when the solution of a compound with an initial concentration c0 is no longer active against the bacteria. The results are given in Table 5.
Substance | k /min–1 | MIC /µg·mL–1 | tTOX /min |
Azi A | 0.39 | 5.9 | 3.13 |
Azi B | 0.31 | 3.94 | |
Ery A | 0.59 | 0.21 | 7.72 |
Ery B | 0.66 | 6.90 | |
Ery A–H2Oa | 0.59 | 7.72 | |
Ery A–H2Ob | 1.11 | 4.10 | |
Spi I | 0.62 | 7.03 | 1.69 |
Spi Ⅲ | 0.64 | 1.63 | |
Tyl A | 2.47 | 1.26 | 1.12 |
Tyl B | 1.66 | 1.67 |
tTOX=−ln(MICc0)k1 | (4) |
Within eight minutes of irradiation, the MIC values were reached, meaning that all observed macrolides were no longer harmful to B. subtilis. Yet, the calculation does not clarify whether the phototransformation products were more active or ecotoxic than the original drug. The phototransformation products observed were mostly sugar compounds. A more detailed picture of whether a photoproduct would be environmentally hazardous may be provided by QSAR analysis.
The QSAR analysis did not predict values for some of the degradation products and organisms, so that comparison with the parent drug was not possible. Generally, irradiation of the substances had a positive effect. It reduced the efficacy of the substances. The detected sugar fragments were predicted to have higher LC50 values than the intact lactone ring scaffold. This would lead to efficacy against the microorganisms tested and hence eco-toxicology. While these increased LC50 values were computed for some degradates, no values reaching into the lower μg L–1 range were predicted. Therefore, the predicted values would still remain well below concentrations found in surface waters.
A comparison between different programs could be achieved on the basis of fathead minnow, a relevant organism to appear in both programs. Here, the values varied by several orders of magnitude and the toxicity were predicted differently for several photoproducts. This could be explained in terms of distinctive databases and calibration models implemented into the programs. Hence, output parameters but also calculation methods were different. The calculation of T.E.S.T. software was based on the database of EUCAST, while in the QSAR toolbox the calculation relied on the data of the European Chemicals Bureau. A literature search for reference data was unsuccessful. Despite the different absolute values, both predictions were consistent when inspecting the parent drug. Most photoproducts investigated were predicted to be potentially less toxic than the parent.
Yet, QSAR methods rely on databases but the prediction is based on structural similarity. As an alternative to a computational approach, MIC values, i.e. experimental data, might be considered for eco-toxicological assessment [36,60]. Recent studies emphasize that IC50 values might be better suitable since they were assay independent [61]. Nevertheless, MIC values are easier and faster to obtain. Additionally, the quality of IC50 values also depends on the completeness of the sigmoidal curve, which might not be obtained under all circumstances. In this study, tylosin served an example for the other macrolides. A tylosin solution was exposed to UV irradiation and MIC values of the solution were determined at various exposure times, see Table 6. Under UV-irradiation the MIC values were expected to increase.
Irradiation time /min | MIC against B. subtilis /mg L–1 |
0 | 1.05 |
1 | 2.1 |
2.5 | 4.2 |
3.5 | > 8.41 |
5 | > 8.41 |
7 | > 8.41 |
From Table 6, it can be seen that the longer tylosin was UV irradiated, the higher the MIC value grew. A maximum was reached between 2.5 min and 3.5 min, indicating that the efficacy of tylosin against B. subtilis decreased. With that loss of potency, it can be assumed that the solution provided no more hazard for the organisms and that the degradation products did not possess higher efficacy and hence potential eco-toxicity than the drug itself. Although this finding was exemplarily demonstrated for tylosin, preliminary studies for other antibiotic classes showed similar results.
The elimination of pharmaceuticals in water bodies using sustainable methods, as demonstrated in this study by using photolysis, was supported by an estimation of toxicity. The hypothesis that such degradation processes might produce substances even more toxic than the parent drug could not be confirmed. In this respect, MIC values were determined and QSAR analysis was performed. Based on four macrolides the products resulting from UV-C irradiation as well as the corresponding solution mixtures formed during irradiation were shown to be less or not ecotoxic in comparison to the parent antibiotic drugs. From these results, the efficacy of UV irradiation for water purification from antibiotics can be assumed. However, for the future of water purification, it is important to consider that there are other pharmaceuticals and anthropogenic micropollutants in waters that have different properties than macrolides. Their concentrations also depend on seasonal and local influences. In consequence, different exposure times and intensities may be needed to achieve complete degradation.
M.V. is grateful for a stipend from the Promotionskolleg of the Niederrhein University of Applied Sciences. The authors thank their institution for further financial support.
All authors declare no conflicts of interest in this paper
[1] | Crick FHC (1956) Ideas on protein synthesis. Wellcome Library for the History and Understanding of Medicine. Avaiable from: http://archives.wellcome.ac.uk/. |
[2] |
Crick FHC (1970) Central Dogma of Molecular Biology. Nature 227: 561–563. doi: 10.1038/227561a0
![]() |
[3] |
Baltimore D (1970) RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature 226: 1209–1211. doi: 10.1038/2261209a0
![]() |
[4] |
Temin HM, Mizutani S (1970) RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature 226: 1211–1213. doi: 10.1038/2261211a0
![]() |
[5] |
Koonin EV (2012) Does the central dogma still stand? Biol Direct 7: 27. doi: 10.1186/1745-6150-7-27
![]() |
[6] |
Melnikov S, Ben-Shem A, Garreau de Loubresse N, et al. (2012) One core, two shells: bacterial and eukaryotic ribosomes. Nat Struct Mol Biol 19: 560–567. doi: 10.1038/nsmb.2313
![]() |
[7] |
Khatter H, Myasnikov AG, Natchiar SK, et al. (2015) Structure of the human 80S ribosome. Nature 520: 640–645. doi: 10.1038/nature14427
![]() |
[8] |
Kolitz SE, Lorsch JR (2010) Eukaryotic initiator tRNA: finely tuned and ready for action. FEBS Lett 584: 396–404. doi: 10.1016/j.febslet.2009.11.047
![]() |
[9] |
Rodnina MV (2016) The ribosome in action: Tuning of translational efficiency and protein folding. Protein Sci 25: 1390–1406. doi: 10.1002/pro.2950
![]() |
[10] |
Dabrowski M, Bukowy-Bieryllo Z, Zietkiewicz E (2015) Translational readthrough potential of natural termination codons in eucaryotes--The impact of RNA sequence. RNA Biol 12: 950–958. doi: 10.1080/15476286.2015.1068497
![]() |
[11] |
Karpinets TV, Greenwood DJ, Sams CE, et al. (2006) RNA:protein ratio of the unicellular organism as a characteristic of phosphorous and nitrogen stoichiometry and of the cellular requirement of ribosomes for protein synthesis. BMC Biol 4: 1–10. doi: 10.1186/1741-7007-4-1
![]() |
[12] |
Ingolia NT, Lareau LF, Weissman JS (2011) Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes. Cell 147: 789–802. doi: 10.1016/j.cell.2011.10.002
![]() |
[13] |
Dennis PP, Bremer H (1974) Differential Rate of Ribosomal Protein Synthesis in Escherichia coli B/r. J Mol Biol 84: 407–422. doi: 10.1016/0022-2836(74)90449-5
![]() |
[14] |
Dennis PP, Nomura M (1974) Stringent Control of Ribosomal Protein Gene Expression in Escherichia coli. Proc Nat Acad Sci USA 71: 3819–3823. doi: 10.1073/pnas.71.10.3819
![]() |
[15] |
Young R, Bremer H (1976) Polypeptide-Chain-Elongation Rate in Escherichia coli B/r as a Function ofGrowth Rate. Biochem J 160: 185–194. doi: 10.1042/bj1600185
![]() |
[16] | Schaaper RM (1993) Base selection, proofreading, and mismatch repair during DNA replication in Escherichia coli. J Biol Chem 268: 23762–23765. |
[17] | Drake JW, Charlesworth B, Charlesworth D, et al. (1998) Rates of spontaneous mutation. Genetics 148: 1667–1686. |
[18] |
Kunkel TA (2004) DNA replication fidelity. J Biol Chem 279: 16895–16898. doi: 10.1074/jbc.R400006200
![]() |
[19] |
Bebenek K, Kunkel TA (2004) Functions of DNA polymerases. Adv Protein Chem 69: 137–165. doi: 10.1016/S0065-3233(04)69005-X
![]() |
[20] |
Kunkel TA (2009) Evolving Views of DNA Replication (In)Fidelity. Cold Spring Harb Sym 74: 91–101. doi: 10.1101/sqb.2009.74.027
![]() |
[21] |
Sainsbury S, Bernecky C, Cramer P (2015) Structural basis of transcription initiation by RNA polymerase II. Nat Rev Mol Cell Biol 16: 129–143. doi: 10.1038/nrm3952
![]() |
[22] |
Sharma N (2016) Regulation of RNA polymerase II-mediated transcriptional elongation: Implications in human disease. IUBMB Life 68: 709–716. doi: 10.1002/iub.1538
![]() |
[23] | Loya TJ, Reines D (2016) Recent advances in understanding transcription termination by RNA polymerase II. F1000 Res 5: 1478. |
[24] |
Schwanhausser B, Busse D, Li N, et al. (2011) Global quantification of mammalian gene expression control. Nature 473: 337–342. doi: 10.1038/nature10098
![]() |
[25] |
Imashimizu M, Oshima T, Lubkowska L, et al. (2013) Direct assessment of transcription fidelity by high-resolution RNA sequencing. Nucleic Acids Res 41: 9090–9104. doi: 10.1093/nar/gkt698
![]() |
[26] |
Ninio J (1991) Connections between translation, transcription and replication error-rates. Biochimie 73: 1517–1523. doi: 10.1016/0300-9084(91)90186-5
![]() |
[27] |
Gouta JF, Thomasb WK, Smithc Z, et al. (2013) Large-scale detection of in vivo transcription errors. PNAS 110: 18584–18589. doi: 10.1073/pnas.1309843110
![]() |
[28] |
Cochella L, Green R (2005) Fidelity in protein synthesis. Curr Biol 15: 536–540. doi: 10.1016/j.cub.2005.02.019
![]() |
[29] | Kramer EB, Farabaugh PJ (2007) The frequency of translational misreading errors in E. coli is largely determined by tRNA competition. RNA 13: 87–96. |
[30] |
Zaher HS, Green R (2009) Fidelity at the molecular level: lessons from protein synthesis. Cell 136: 746–762. doi: 10.1016/j.cell.2009.01.036
![]() |
[31] | Gingold H, Pilpel Y (2011) Determinants of translation efficiency and accuracy. Mol Syst Biol 7: 141–150. |
[32] |
Ribas de Pouplana L, Santos MA, Zhu JH, et al. (2014) Protein mistranslation: friend or foe? Trends Biochem Sci 39: 355–362. doi: 10.1016/j.tibs.2014.06.002
![]() |
[33] |
Anfinsen CB (1973) Principles that govern the folding of protein chains. Science 181: 223–230. doi: 10.1126/science.181.4096.223
![]() |
[34] |
Bulik S, Peters B, Holzhutter HG (2005) Quantifying the Contribution of Defective Ribosomal Products to Antigen Production: A Model-Based Computational Analysis. J Immunol 175: 7957–7964. doi: 10.4049/jimmunol.175.12.7957
![]() |
[35] |
Vabulas RM, Hartl FU (2005) Protein synthesis upon acute nutrient restriction relies on proteasome function. Science 310: 1960–1963. doi: 10.1126/science.1121925
![]() |
[36] |
Schubert U, Antón LC, Gibbs J, et al. (2000) Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404: 770–774. doi: 10.1038/35008096
![]() |
[37] |
Vabulas RM, Hartl UF (2005) Protein Synthesis upon Acute Nutrient Restriction Relies on Proteasome Function. Science 310: 1960–1963. doi: 10.1126/science.1121925
![]() |
[38] | Hung MC, Link W (2011) Protein localization in disease and therapy. J Cell Sci 124: 3381–3392. |
[39] |
Chacinska A, Koehler CM, Milenkovic D, et al. (2009) Importing mitochondrial proteins: machineries and mechanisms. Cell 138: 628–644. doi: 10.1016/j.cell.2009.08.005
![]() |
[40] |
Rapoport TA (2007) Protein translocation across the eukaryotic endoplasmic reticulum and bacterial plasma membranes. Nature 450: 663–669. doi: 10.1038/nature06384
![]() |
[41] |
Geva Y, Schuldiner M (2014) The back and forth of cargo exit from the endoplasmic reticulum. Curr Biol 24: 130–136. doi: 10.1016/j.cub.2013.12.008
![]() |
[42] |
Barlowe C, Helenius A (2016) Cargo Capture and Bulk Flow in the Early Secretory Pathway. Annu Rev Cell Dev Biol 32: 197–222. doi: 10.1146/annurev-cellbio-111315-125016
![]() |
[43] |
Herrmann JM, Neupert W (2000) Protein transport into mitochondria. Curr Opin Microbiol 3: 210–214. doi: 10.1016/S1369-5274(00)00077-1
![]() |
[44] |
Zimmermann R, Eyrisch S, Ahmad M, et al. (2011) Protein translocation across the ER membrane. Biochim Biophys Acta 1808: 912–924. doi: 10.1016/j.bbamem.2010.06.015
![]() |
[45] |
Freitas N, Cunha C (2009) Mechanisms and signals for the nuclear import of proteins. Curr Genomics 10: 550–557. doi: 10.2174/138920209789503941
![]() |
[46] |
Nichols WC, Seligsohn U, Zivelin A, et al. (1998) Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII. Cell 93: 61–70. doi: 10.1016/S0092-8674(00)81146-0
![]() |
[47] |
Spreafico M, Peyvandi F (2009) Combined Factor V and Factor VIII Deficiency. Semin Thromb Hemost 35: 390–399. doi: 10.1055/s-0029-1225761
![]() |
[48] |
Rock KL, Gramm C, Rothstein L, et al. (1994) Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78: 761–771. doi: 10.1016/S0092-8674(94)90462-6
![]() |
[49] |
Goldberg AL (2003) Protein degradation and protection against misfolded or damaged proteins. Nature 426: 895–899. doi: 10.1038/nature02263
![]() |
[50] |
Finley D (2009) Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem 78: 477–513. doi: 10.1146/annurev.biochem.78.081507.101607
![]() |
[51] |
Rock KL, Farfan-Arribas DJ, Colbert JD, et al. (2014) Re-examining class-I presentation and the DRiP hypothesis. Trends Immunol 35: 144–152. doi: 10.1016/j.it.2014.01.002
![]() |
[52] | Cohen-Kaplan V, Livneh I, Avni N, et al. (2016) The ubiquitin-proteasome system and autophagy: Coordinated and independent activities. Int J Biochem Cell Biol: In Press. |
[53] |
Ravikumar B, Sarkar S, Davies JE, et al. (2010) Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev 90: 1383–1435. doi: 10.1152/physrev.00030.2009
![]() |
[54] |
Mariappan M, Li X, Stefanovic S, et al. (2010) A ribosome-associating factor chaperones tail-anchored membrane proteins. Nature 466: 1120–1124. doi: 10.1038/nature09296
![]() |
[55] |
Brandman O, Stewart-Ornstein J, Wong D, et al. (2012) A ribosome-bound quality control complex triggers degradation of nascent peptides and signals translation stress. Cell 151: 1042–1054. doi: 10.1016/j.cell.2012.10.044
![]() |
[56] |
Defenouillère Q, Yao Y, Mouaikel J, et al. (2013) Cdc48 associated complex bound to 60s particles is required for the clearance of aberrant translation products. PNAS 110: 5046–5051. doi: 10.1073/pnas.1221724110
![]() |
[57] |
Shao S, von der Malsburg K, Hegde RS (2013) Listerin-dependent nascent protein ubiquitination relies on ribosome subunit dissociation. Mol Cell 50: 637–648. doi: 10.1016/j.molcel.2013.04.015
![]() |
[58] | Verma R, Oania RS, Kolawa1 NJ, et al. (2013) Cdc48/p97 promotes degradation of aberrant nascent polypeptides bound to the ribosome. eLife 2: e00308. |
[59] | Shen PS, Park J, Qin Y, et al. (2016) Rqc2p and 60S ribosomal subunits mediate mRNA-independent elongation of nascent chains. Science 347: 75–78. |
[60] |
Ghaemmaghami S, Huh WK, Bower K, et al. (2003) Global analysis of protein expression in yeast. Nature 425: 737–741. doi: 10.1038/nature02046
![]() |
[61] |
Schwarz F, Aebi M (2011) Mechanisms and principles of N-linked protein glycosylation. Curr Opin Struct Biol 21: 576–582. doi: 10.1016/j.sbi.2011.08.005
![]() |
[62] |
Tannous A, Pisoni GB, Hebert DN, et al. (2015) N-linked sugar-regulated protein folding and quality control in the ER. Semin Cell Dev Biol 41: 79–89. doi: 10.1016/j.semcdb.2014.12.001
![]() |
[63] |
Ellgaard L, Molinari M, Helenius A (1999) Setting the standards: quality control in the secretory pathway. Science 286: 1882–1888. doi: 10.1126/science.286.5446.1882
![]() |
[64] |
Aebi M, Bernasconi R, Clerc S, et al. (2010) N-glycan structures: recognition and processing in the ER. Trends Biochem Sci 35: 74–82. doi: 10.1016/j.tibs.2009.10.001
![]() |
[65] |
Schallus T, Feher K, Sternberg U, et al. (2010) Analysis of the specific interactions between the lectin domain of malectin and diglucosides. Glycobiology 20: 1010–1020. doi: 10.1093/glycob/cwq059
![]() |
[66] |
Galli C, Bernasconi R, Solda T, et al. (2011) Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. PLoS One 6: e16304. doi: 10.1371/journal.pone.0016304
![]() |
[67] |
Pisoni GB, Ruddock LW, Bulleid N, et al. (2015) Division of labor among oxidoreductases: TMX1 preferentially acts on transmembrane polypeptides. Mol Biol Cell 26: 3390–3400. doi: 10.1091/mbc.E15-05-0321
![]() |
[68] |
Lamriben L, Graham JB, Adams BM, et al. (2016) N-Glycan-based ER Molecular Chaperone and Protein Quality Control System: The Calnexin Binding Cycle. Traffic 17: 308–326. doi: 10.1111/tra.12358
![]() |
[69] |
Cabral CM, Choudhury P, Liu Y, et al. (2000) Processing by endoplasmic reticulum mannosidases partitions a secretion-impaired glycoprotein into distinct disposal pathways. J Biol Chem 275: 25015–25022. doi: 10.1074/jbc.M910172199
![]() |
[70] |
Olivari S, Cali T, Salo KE, et al. (2006) EDEM1 regulates ER-associated degradation by accelerating de-mannosylation of folding-defective polypeptides and by inhibiting their covalent aggregation. Biochem Biophys Res Commun 349: 1278–1284. doi: 10.1016/j.bbrc.2006.08.186
![]() |
[71] |
Ninagawa S, Okada T, Sumitomo Y, et al. (2014) EDEM2 initiates mammalian glycoprotein ERAD by catalyzing the first mannose trimming step. J Cell Biol 206: 347–356. doi: 10.1083/jcb.201404075
![]() |
[72] |
Hirao K, Natsuka Y, Tamura T, et al. (2006) EDEM3, a soluble EDEM homolog, enhances glycoprotein endoplasmic reticulum-associated degradation and mannose trimming. J Biol Chem 281: 9650–9658. doi: 10.1074/jbc.M512191200
![]() |
[73] |
Olivari S, Molinari M (2007) Glycoprotein folding and the role of EDEM1, EDEM2 and EDEM3 in degradation of folding-defective glycoproteins. FEBS Lett 581: 3658–3664. doi: 10.1016/j.febslet.2007.04.070
![]() |
[74] |
Christianson JC, Shaler TA, Tyler RE, et al. (2008) OS-9 and GRP94 deliver mutant alpha1-antitrypsin to the Hrd1-SEL1L ubiquitin ligase complex for ERAD. Nat Cell Biol 10: 272–282. doi: 10.1038/ncb1689
![]() |
[75] |
Bernasconi R, Galli C, Calanca V, et al. (2010) Stringent requirement for HRD1, SEL1L, and OS-9/XTP3-B for disposal of ERAD-LS substrates. J Cell Biol 188: 223–235. doi: 10.1083/jcb.200910042
![]() |
[76] |
Vembar SS, Brodsky JL (2008) One step at a time: endoplasmic reticulum-associated degradation. Nat Rev Mol Cell Biol 9: 944–957. doi: 10.1038/nrm2546
![]() |
[77] |
Merulla J, Solda T, Molinari M (2015) A novel UGGT1 and p97-dependent checkpoint for native ectodomains with ionizable intramembrane residue. Mol Biol Cell 26: 1532–1542. doi: 10.1091/mbc.E14-12-1615
![]() |
[78] |
Merulla J, Fasana E, Solda T, et al. (2013) Specificity and regulation of the endoplasmic reticulum-associated degradation machinery. Traffic 14: 767–777. doi: 10.1111/tra.12068
![]() |
[79] |
Bernasconi R, Molinari M (2011) ERAD and ERAD tuning: disposal of cargo and of ERAD regulators from the mammalian ER. Curr Opin Cell Biol 23: 176–183. doi: 10.1016/j.ceb.2010.10.002
![]() |
[80] |
Koenig PA, Nicholls PK, Schmidt FI, et al. (2014) The E2 ubiquitin-conjugating enzyme UBE2J1 is required for spermiogenesis in mice. J Biol Chem 289: 34490–34502. doi: 10.1074/jbc.M114.604132
![]() |
[81] |
Hagiwara M, Ling J, Koenig PA, et al. (2016) Posttranscriptional Regulation of Glycoprotein Quality Control in the Endoplasmic Reticulum Is Controlled by the E2 Ub-Conjugating Enzyme UBC6e. Mol Cell 63: 753–767. doi: 10.1016/j.molcel.2016.07.014
![]() |
[82] |
Glick D, Barth S, Macleod KF (2010) Autophagy: cellular and molecular mechanisms. J Pathol 221: 3–12. doi: 10.1002/path.2697
![]() |
[83] |
Mizushima N, Ohsumi Y, Yoshimori T (2002) Autophagosome Formation in Mammalian Cells. Cell Struct Funct 27: 421–429. doi: 10.1247/csf.27.421
![]() |
[84] |
Ohsumi Y (2014) Historical landmarks of autophagy research. Cell Res 24: 9–23. doi: 10.1038/cr.2013.169
![]() |
[85] | Ariosa AR, Klionsky DJ (2016) Autophagy core machinery: overcoming spatial barriers in neurons. J Mol Med (Berl): In Press. |
[86] |
Ryter SW, Cloonan SM, Choi AM (2013) Autophagy: a critical regulator of cellular metabolism and homeostasis. Mol Cells 36: 7–16. doi: 10.1007/s10059-013-0140-8
![]() |
[87] |
Choi AM, Ryter SW, Levine B (2013) Autophagy in human health and disease. N Engl J Med 368: 1845–1846. doi: 10.1056/NEJMc1303158
![]() |
[88] | Lin F, Qin ZH (2013) Degradation of misfolded proteins by autophagy: is it a strategy for Huntington's disease treatment? J Huntingtons Dis 2: 149–157. |
[89] |
Webb JL, Ravikumar B, Atkins J, et al. (2003) Alpha-Synuclein is degraded by both autophagy and the proteasome. J Biol Chem 278: 25009–25013. doi: 10.1074/jbc.M300227200
![]() |
[90] | Pickford F, Masliah E, Britschgi M, et al. (2008) The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J Clin Invest 118: 2190–2199. |
[91] |
Lee MJ, Lee JH, Rubinsztein DC (2013) Tau degradation: the ubiquitin-proteasome system versus the autophagy-lysosome system. Prog Neurobiol 105: 49–59. doi: 10.1016/j.pneurobio.2013.03.001
![]() |
[92] |
Perlmutter DH (2011) Alpha-1-antitrypsin deficiency: importance of proteasomal and autophagic degradative pathways in disposal of liver disease-associated protein aggregates. Annu Rev Med 62: 333–345. doi: 10.1146/annurev-med-042409-151920
![]() |
[93] |
Fu L, Sztul E (2009) ER-associated complexes (ERACs) containing aggregated cystic fibrosis transmembrane conductance regulator (CFTR) are degraded by autophagy. Eur J Cell Biol 88: 215–226. doi: 10.1016/j.ejcb.2008.11.003
![]() |
[94] | Farre JC, Subramani S (2016) Mechanistic insights into selective autophagy pathways: lessons from yeast. Nat Rev Mol Cell Biol 17: 537–552. |
[95] |
Khaminets A, Heinrich T, Mari M, et al. (2015) Regulation of endoplasmic reticulum turnover by selective autophagy. Nature 522: 354–358. doi: 10.1038/nature14498
![]() |
[96] | Fumagalli FNJ, Bergmann TJ, Cebollero E, et al. (2016) Translocon component Sec62 acts in endoplasmic reticulum turnover during stress recovery. Nat Cell Biol: In press. |
[97] |
Inoue T, Tsai B (2013) How viruses use the endoplasmic reticulum for entry, replication, and assembly. Cold Spring Harb Perspect Biol 5: a013250. doi: 10.1101/cshperspect.a013250
![]() |
[98] |
van den Boomen DJ, Lehner PJ (2015) Identifying the ERAD ubiquitin E3 ligases for viral and cellular targeting of MHC class I. Mol Immunol 68: 106–111. doi: 10.1016/j.molimm.2015.07.005
![]() |
[99] | Gardner BM, Pincus D, Gotthardt K, et al. (2013) Endoplasmic reticulum stress sensing in the unfolded protein response. Cold Spring Harb Perspect Biol 5: a013169. |
[100] |
Mori K (2009) Signalling pathways in the unfolded protein response: development from yeast to mammals. J Biochem 146: 743–750. doi: 10.1093/jb/mvp166
![]() |
[101] |
Zhang L, Zhang C, Wang A (2016) Divergence and Conservation of the Major UPR Branch IRE1-bZIP Signaling Pathway across Eukaryotes. Sci Rep 6: 27362. doi: 10.1038/srep27362
![]() |
[102] |
Lee AH, Iwakoshi NN, Glimcher LH (2003) XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol 23: 7448–7459. doi: 10.1128/MCB.23.21.7448-7459.2003
![]() |
[103] |
Hollien J, Weissman JS (2006) Decay of endoplasmic reticulum-localized mRNAs during the unfolded protein response. Science 313: 104–107. doi: 10.1126/science.1129631
![]() |
[104] |
Haze K, Yoshida H, Yanagi H, et al. (1999) Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol Biol Cell 10: 3787–3799. doi: 10.1091/mbc.10.11.3787
![]() |
[105] |
Shoulders MD, Ryno LM, Genereux JC, et al. (2013) Stress-independent activation of XBP1s and/or ATF6 reveals three functionally diverse ER proteostasis environments. Cell Rep 3: 1279–1292. doi: 10.1016/j.celrep.2013.03.024
![]() |
[106] |
Bertolotti A, Zhang Y, Hendershot LM, et al. (2000) Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat Cell Biol 2: 326–332. doi: 10.1038/35014014
![]() |
[107] |
Harding HP, Zhang Y, Ron D (1999) Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 397: 271–274. doi: 10.1038/16729
![]() |
[108] |
Vattem KM, Wek RC (2004) Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells. Proc Natl Acad Sci U S A 101: 11269–11274. doi: 10.1073/pnas.0400541101
![]() |
[109] |
Lu PD, Harding HP, Ron D (2004) Translation reinitiation at alternative open reading frames regulates gene expression in an integrated stress response. J Cell Biol 167: 27–33. doi: 10.1083/jcb.200408003
![]() |
[110] |
Jiang HY, Wek SA, McGrath BC, et al. (2004) Activating transcription factor 3 is integral to the eukaryotic initiation factor 2 kinase stress response. Mol Cell Biol 24: 1365–1377. doi: 10.1128/MCB.24.3.1365-1377.2004
![]() |
[111] |
Schroder M, Kaufman RJ (2005) ER stress and the unfolded protein response. Mutat Res 569: 29–63. doi: 10.1016/j.mrfmmm.2004.06.056
![]() |
[112] |
Redler RL, Das J, Diaz JR, et al. (2016) Protein Destabilization as a Common Factor in Diverse Inherited Disorders. J Mol Evol 82: 11–16. doi: 10.1007/s00239-015-9717-5
![]() |
[113] |
Sitia R, Braakman I (2003) Quality control in the endoplasmic reticulum protein factory. Nature 426: 891–894. doi: 10.1038/nature02262
![]() |
[114] |
Bernier V, Lagace M, Bichet DG, et al. (2004) Pharmacological chaperones: potential treatment for conformational diseases. Trends Endocrinol Metab 15: 222–228. doi: 10.1016/j.tem.2004.05.003
![]() |
[115] |
Molinari M (2007) N-glycan structure dictates extension of protein folding or onset of disposal. Nat Chem Biol 3: 313–320. doi: 10.1038/nchembio880
![]() |
[116] |
Kopito RR, Ron D (2000) Conformational disease. Nat Cell Biol 2: 207–209. doi: 10.1038/35041139
![]() |
[117] |
Gidalevitz T, Ben-Zvi A, Ho KH, et al. (2006) Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science 311: 1471–1474. doi: 10.1126/science.1124514
![]() |
[118] |
Powers ET, Morimoto RI, Dillin A, et al. (2009) Biological and chemical approaches to diseases of proteostasis deficiency. Annu Rev Biochem 78: 959–991. doi: 10.1146/annurev.biochem.052308.114844
![]() |
[119] |
Morello JP, Petaja-Repo UE, Bichet DG, et al. (2000) Pharmacological chaperones: a new twist on receptor folding. Trends Pharmacol Sci 21: 466–469. doi: 10.1016/S0165-6147(00)01575-3
![]() |
[120] |
Cohen FE, Kelly JW (2003) Therapeutic approaches to protein-misfolding diseases. Nature 426: 905–909. doi: 10.1038/nature02265
![]() |
[121] |
Convertino M, Das J, Dokholyan NV (2016) Pharmacological Chaperones: Design and Development of New Therapeutic Strategies for the Treatment of Conformational Diseases. ACS Chem Biol 11: 1471–1489. doi: 10.1021/acschembio.6b00195
![]() |
[122] |
Ma Y, Hendershot LM (2004) The role of the unfolded protein response in tumour development: friend or foe? Nat Rev Cancer 4: 966–977. doi: 10.1038/nrc1505
![]() |
[123] |
Fernandez PM, Tabbara SO, Jacobs LK, et al. (2000) Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions. Breast Cancer Res Treat 59: 15–26. doi: 10.1023/A:1006332011207
![]() |
[124] | Shuda M, Kondoh N, Imazeki N, et al. (2003) Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis. J Hepatol 38: 605–614. |
[125] | Song MS, Park YK, Lee JH, et al. (2001) Induction of glucose-regulated protein 78 by chronic hypoxia in human gastric tumor cells through a protein kinase C-epsilon/ERK/AP-1 signaling cascade. Cancer Res 61: 8322–8330. |
[126] |
Gazit G, Lu J, Lee AS (1999) De-regulation of GRP stress protein expression in human breast cancer cell lines. Breast Cancer Res Treat 54: 135–146. doi: 10.1023/A:1006102411439
![]() |
[127] | Plate L, Paxman RJ, Wiseman RL, et al. (2016) Modulating protein quality control. Elife 5: e18431. |
[128] |
Wang X, Venable J, LaPointe P, et al. (2006) Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell 127: 803–815. doi: 10.1016/j.cell.2006.09.043
![]() |
[129] |
Mu TW, Ong DS, Wang YJ, et al. (2008) Chemical and biological approaches synergize to ameliorate protein-folding diseases. Cell 134: 769–781. doi: 10.1016/j.cell.2008.06.037
![]() |
[130] |
Chiang WC, Hiramatsu N, Messah C, et al. (2012) Selective activation of ATF6 and PERK endoplasmic reticulum stress signaling pathways prevent mutant rhodopsin accumulation. Invest Ophthalmol Vis Sci 53: 7159–7166. doi: 10.1167/iovs.12-10222
![]() |
[131] |
Luheshi LM, Dobson CM (2009) Bridging the gap: from protein misfolding to protein misfolding diseases. FEBS Lett 583: 2581–2586. doi: 10.1016/j.febslet.2009.06.030
![]() |
[132] |
Braakman I, Bulleid NJ (2011) Protein folding and modification in the mammalian endoplasmic reticulum. Annu Rev Biochem 80: 71–99. doi: 10.1146/annurev-biochem-062209-093836
![]() |
[133] |
Brodsky JL, Skach WR (2011) Protein folding and quality control in the endoplasmic reticulum: Recent lessons from yeast and mammalian cell systems. Curr Opin Cell Biol 23: 464–475. doi: 10.1016/j.ceb.2011.05.004
![]() |
[134] |
Papa FR, Zhang C, Shokat K, et al. (2003) Bypassing a kinase activity with an ATP-competitive drug. Science 302: 1533–1537. doi: 10.1126/science.1090031
![]() |
[135] |
Wiseman RL, Zhang Y, Lee KP, et al. (2010) Flavonol activation defines an unanticipated ligand-binding site in the kinase-RNase domain of IRE1. Mol Cell 38: 291–304. doi: 10.1016/j.molcel.2010.04.001
![]() |
[136] |
Wang L, Perera BG, Hari SB, et al. (2012) Divergent allosteric control of the IRE1alpha endoribonuclease using kinase inhibitors. Nat Chem Biol 8: 982–989. doi: 10.1038/nchembio.1094
![]() |
[137] | Sidrauski C, Tsai JC, Kampmann M, et al. (2015) Pharmacological dimerization and activation of the exchange factor eIF2B antagonizes the integrated stress response. Elife 4: e07314. |
[138] |
Robblee MM, Kim CC, Porter Abate J, et al. (2016) Saturated Fatty Acids Engage an IRE1alpha-Dependent Pathway to Activate the NLRP3 Inflammasome in Myeloid Cells. Cell Rep 14: 2611–2623. doi: 10.1016/j.celrep.2016.02.053
![]() |
[139] | Gallagher CM, Walter P (2016) Ceapins inhibit ATF6alpha signaling by selectively preventing transport of ATF6alpha to the Golgi apparatus during ER stress. Elife 5: e11880. |
[140] | Gallagher CM, Garri C, Cain EL, et al. (2016) Ceapins are a new class of unfolded protein response inhibitors, selectively targeting the ATF6alpha branch. Elife 5: e11880. |
[141] | Plate L, Cooley CB, Chen JJ, et al. (2016) Small molecule proteostasis regulators that reprogram the ER to reduce extracellular protein aggregation. Elife 5: e15550. |
[142] |
Hsu PD, Lander ES, Zhang F (2014) Development and applications of CRISPR-Cas9 for genome engineering. Cell 157: 1262–1278. doi: 10.1016/j.cell.2014.05.010
![]() |
1. | Ethan Hain, Hollie Adejumo, Bridget Anger, Joseph Orenstein, Lee Blaney, Advances in antimicrobial activity analysis of fluoroquinolone, macrolide, sulfonamide, and tetracycline antibiotics for environmental applications through improved bacteria selection, 2021, 03043894, 125686, 10.1016/j.jhazmat.2021.125686 | |
2. | Melanie Voigt, Alexander Wirtz, Kerstin Hoffmann-Jacobsen, Martin Jaeger, Prior art for the development of a fourth purification stage in wastewater treatment plant for the elimination of anthropogenic micropollutants-a short-review, 2020, 7, 2372-0352, 69, 10.3934/environsci.2020005 | |
3. | Melanie Voigt, Benjamin Hentschel, Nina Theiss, Christina Savelsberg, Indra Bartels, Anna Nickisch-Hartfiel, Martin Jaeger, Lomefloxacin—Occurrence in the German River Erft, Its Photo-Induced Elimination, and Assessment of Ecotoxicity, 2020, 2, 2571-8797, 74, 10.3390/cleantechnol2010006 | |
4. | Wei Li, Baoling Lyu, Jiping Li, Gregory V. Korshin, Meng Zhang, Yinlong Zhang, Pingping Li, Jiangang Han, Phototransformation of roxithromycin in the presence of dissolved organic matter: Characteriazation of the degradation products and toxicity evaluation, 2020, 733, 00489697, 139348, 10.1016/j.scitotenv.2020.139348 | |
5. | Melanie Voigt, Martin Jaeger, Structure and QSAR analysis of photoinduced transformation products of neonicotinoids from EU watchlist for ecotoxicological assessment, 2021, 751, 00489697, 141634, 10.1016/j.scitotenv.2020.141634 | |
6. | Melanie Voigt, Indra Bartels, Anna Nickisch-Hartfiel, Martin Jaeger, Determination of minimum inhibitory concentration and half maximal inhibitory concentration of antibiotics and their degradation products to assess the eco-toxicological potential, 2019, 101, 0277-2248, 315, 10.1080/02772248.2019.1687706 | |
7. | Melanie Voigt, Indra Bartels, Dorothee Schmiemann, Lars Votel, Kerstin Hoffmann-Jacobsen, Martin Jaeger, Metoprolol and Its Degradation and Transformation Products Using AOPs—Assessment of Aquatic Ecotoxicity Using QSAR, 2021, 26, 1420-3049, 3102, 10.3390/molecules26113102 | |
8. | Dorothee Schmiemann, Lisa Hohenschon, Indra Bartels, Andrea Hermsen, Felix Bachmann, Arno Cordes, Martin Jäger, Jochen Stefan Gutmann, Kerstin Hoffmann-Jacobsen, Enzymatic post-treatment of ozonation: laccase-mediated removal of the by-products of acetaminophen ozonation, 2023, 1614-7499, 10.1007/s11356-023-25913-w | |
9. | Yichen Xu, Yutong Zhang, Xinhao Wang, Zhe Wang, Liuqing Huang, Hao Wu, Jinghua Ren, Cheng Gu, Zhanghao Chen, Enhanced photodegradation of tylosin in the presence of natural montmorillonite: Synergistic effects of adsorption and surface hydroxyl radicals, 2023, 855, 00489697, 158750, 10.1016/j.scitotenv.2022.158750 | |
10. | Shaoqing Zhang, Jia-Qian Jiang, Michael Petri, Removing imidacloprid, bisphenol-S and azithromycin by ferrate (Fe(VI)): efficiency, oxidation products, toxicity and kinetics, 2022, 8, 26670100, 100552, 10.1016/j.envc.2022.100552 | |
11. | Klaudia Stando, Patrycja Kasprzyk, Ewa Felis, Sylwia Bajkacz, Heterogeneous Photocatalysis of Metronidazole in Aquatic Samples, 2021, 26, 1420-3049, 7612, 10.3390/molecules26247612 | |
12. | Qingjiang Yuan, Meiping Sui, Chengzhi Qin, Hongying Zhang, Yingjie Sun, Siyi Luo, Jianwei Zhao, Migration, Transformation and Removal of Macrolide Antibiotics in The Environment: A Review, 2022, 29, 0944-1344, 26045, 10.1007/s11356-021-18251-2 | |
13. | Melanie Voigt, Victoria Langerbein, Martin Jaeger, In silico ecotoxicity assessment of photoinduced imidacloprid degradation using HPLC–HRMS, QSAR and ecotoxicity equivalents, 2022, 34, 2190-4707, 10.1186/s12302-022-00616-0 | |
14. | Lua Vazquez, Lúcio M.M.T. Gomes, Pedro H. Presumido, Daniela G.D. Rocca, Regina F.P.M. Moreira, Thierry Dagnac, Maria Llompart, Ana I. Gomes, Vítor J.P. Vilar, Tubular membrane photoreactor for the tertiary treatment of urban wastewater towards antibiotics removal: application of different photocatalyst/oxidant combinations and ozonation, 2023, 22133437, 109766, 10.1016/j.jece.2023.109766 | |
15. | Nasser Ibrahim Zouli, Photodegradation of a Broad-Spectrum Antibiotic Azithromycin Using H2O2 under Ultraviolet Irradiation, 2024, 25, 1422-0067, 6702, 10.3390/ijms25126702 | |
16. | Klaudia Stando, Paulina Zogornik, Marta Kopiec, Martyna Pieszczek, Katarzyna Kowalska, Ewa Felis, Sylwia Bajkacz, Degradation of fluoroquinolones and macrolides by solar light-driven heterogeneous photocatalysis – Proposed drug transformation pathways, 2024, 453, 10106030, 115651, 10.1016/j.jphotochem.2024.115651 |
compound | theoretical [M+H]+ | observed [M+H]+ | fragments | structure |
Azi A | 749.5158 | 749.5258 | 591.4215; 375.2667 |
![]() |
Azi B | 733.5209 | 733.5300 | 575.4329; 367.2689 |
![]() |
Ery A | 734.4685 | 734.4732 | 576.3794; 558.3669 |
![]() |
Ery B | 718.4736 | 718.4785 | 542.3717 | ![]() |
Ery A-H2Oa | 716.4580 | 716.4619 | - | |
Ery A-H2Ob | 716.4580 | 716.4623 | - | |
SpiI | 843.5213 | 843.5269 | 438.2800; 422.2667; 781.5456 |
![]() |
SpiⅢ | 899.5475 | 899.5485 | - | ![]() |
Tyl A | 916.5264 | 916.5374 | 742.4372; 582.3637; 336.2019 |
![]() |
Tyl B | 772.4478 | 772.4559 | 598.3348; 582.3637 |
![]() |
Substance | k /min–1 | t1/2 /min | Φ254 |
Azi A | 0.39 | 1.80 | 1.02 |
Azi B | 0.31 | 2.23 | 0.81 |
Ery A | 0.59 | 1.18 | 0.55 |
Ery B | 0.66 | 1.04 | 0.61 |
Ery A–H2Oa | 0.59 | 1.17 | 0.55 |
Ery A–H2Ob | 1.11 | 0.63 | 1.03 |
Spi I | 0.62 | 1.12 | 0.05 |
Spi Ⅲ | 0.64 | 1.08 | 0.05 |
Tyl A | 2.47 | 0.28 | 0.04 |
Tyl B | 1.66 | 0.42 | 0.03 |
substance | photo-degradates | Rt /min | theoretical [M+H]+ | observed [M+H]+ | fragments |
Azithromycin | 192 | 0.5 | 192.123 | 192.126 | - |
591 | 4.8 | 591.422 | 591.427 | 434.315; 296.217 |
|
434 | 5.2 | 434.312 | 434.315 | - | |
735 | 5.4 | 735.500 | 735.506 | 591.426; 368.257 |
|
592 | 8.5 | 592.406 | 592.408 | 300.278; 237.102 |
|
720 | 8.8 | 720.453 | 720.462 | 540.308; 375.266; 250.994 |
|
Erythromycin | 192 | 0.6 | 192.123 | 192.123 | - |
720 | 7.5 | 720.452 | 720.457 | 558.366; 460.414; 375.263 |
|
Spiramycin | 160 | 0.6 | 160.133 | 160.134 | 142.123 |
322 | 3.2 | 322.186 | 322,185 | 118.086 | |
336 a | 3.7 | 336.202 | 336.204 | 192.122; 174.111; 145.084; 127.074; 101.059 |
|
336 b | 4.4 | 336.202 | 336.204 | 192.122; 174.111; 145.084; 127.074; 101.059 |
|
Tylosin | 192 | 1.1 | 192.123 | 192.123 | - |
215 | 1.8 | 215.128 | 215.090 | - | |
352 | 3.7 | 352.196 | - | ||
336 | 4.2 | 336.202 | 336.201 | - |
compound | MIC against B. subtilis /µg mL–1 | MIC against Ps. fluorescens /µg mL–1 | Daphnia magna LC50 (48 h) mg/La | Fathead minnow LC50 (96 h) mg/La | Fathead minnow LC50 (96 h) mg/Lb, c | Branchiopoda LC50 (48 h) mg/Lb, d |
Azi A | 5.90 | 49.48 | 80.84 | 0.33 | - | 3.04 |
Azi B | 72.43 | 0.87 | - | 2.22 | ||
735 | 98.37 | 0.14 | - | 3.99 | ||
720 | 202.02 | - | - | 28.4 | ||
592 | 108.58 | 0.04 | - | 23.4 | ||
591 | 151.56 | 0.10 | - | 3.26 | ||
434 | 97.23 | 4.09 | 695 | 23.3 | ||
192 | 2067.67 | 4087.53 | 1.58E5 | 1780 | ||
Ery A | 0.21 | 96.90 | 135.5 | - | - | 8.6 |
Ery B | 127.65 | - | - | 0.98 | ||
Ery C | 193.84 | - | 340 | 11.3 | ||
Ery F | 333.08 | - | - | 68.4 | ||
716 | 129.61 | - | 193 | 6.36 | ||
192 | 2067.67 | 4087.53 | 1.58E5 | 1780 | ||
Spi I | 7.03 | 177.75 | 69.14 | - | - | 97 |
Spi Ⅲ | 15.00 | - | - | 34.2 | ||
336 | 579.58 | 410.60 | 2.69E5 | - | ||
322 | 666.63 | 547.26 | 4E5 | - | ||
160 | 367.72 | 1062.61 | 1.88E4 | - | ||
702 | 211.54 | - | - | 703 | ||
Tyl A | 1.26 | 160.80 | 104.55 | - | - | 426 |
Tyl B | 76.56 | - | - | 264 | ||
352 | 347.51 | 683.37 | 4.39E4 | - | ||
336 | 579.58 | 410.60 | 2.69E5 | - | ||
215 | 90.11 | 246.51 | 551 | - | ||
192 | 2067.67 | 4087.53 | 1.58E5 | 1780 | ||
a T.E.S.T b QSAR Toolbox c Pimephales promelas d undefined testorganisms |
Substance | k /min–1 | MIC /µg·mL–1 | tTOX /min |
Azi A | 0.39 | 5.9 | 3.13 |
Azi B | 0.31 | 3.94 | |
Ery A | 0.59 | 0.21 | 7.72 |
Ery B | 0.66 | 6.90 | |
Ery A–H2Oa | 0.59 | 7.72 | |
Ery A–H2Ob | 1.11 | 4.10 | |
Spi I | 0.62 | 7.03 | 1.69 |
Spi Ⅲ | 0.64 | 1.63 | |
Tyl A | 2.47 | 1.26 | 1.12 |
Tyl B | 1.66 | 1.67 |
Irradiation time /min | MIC against B. subtilis /mg L–1 |
0 | 1.05 |
1 | 2.1 |
2.5 | 4.2 |
3.5 | > 8.41 |
5 | > 8.41 |
7 | > 8.41 |
compound | theoretical [M+H]+ | observed [M+H]+ | fragments | structure |
Azi A | 749.5158 | 749.5258 | 591.4215; 375.2667 |
![]() |
Azi B | 733.5209 | 733.5300 | 575.4329; 367.2689 |
![]() |
Ery A | 734.4685 | 734.4732 | 576.3794; 558.3669 |
![]() |
Ery B | 718.4736 | 718.4785 | 542.3717 | ![]() |
Ery A-H2Oa | 716.4580 | 716.4619 | - | |
Ery A-H2Ob | 716.4580 | 716.4623 | - | |
SpiI | 843.5213 | 843.5269 | 438.2800; 422.2667; 781.5456 |
![]() |
SpiⅢ | 899.5475 | 899.5485 | - | ![]() |
Tyl A | 916.5264 | 916.5374 | 742.4372; 582.3637; 336.2019 |
![]() |
Tyl B | 772.4478 | 772.4559 | 598.3348; 582.3637 |
![]() |
Substance | k /min–1 | t1/2 /min | Φ254 |
Azi A | 0.39 | 1.80 | 1.02 |
Azi B | 0.31 | 2.23 | 0.81 |
Ery A | 0.59 | 1.18 | 0.55 |
Ery B | 0.66 | 1.04 | 0.61 |
Ery A–H2Oa | 0.59 | 1.17 | 0.55 |
Ery A–H2Ob | 1.11 | 0.63 | 1.03 |
Spi I | 0.62 | 1.12 | 0.05 |
Spi Ⅲ | 0.64 | 1.08 | 0.05 |
Tyl A | 2.47 | 0.28 | 0.04 |
Tyl B | 1.66 | 0.42 | 0.03 |
substance | photo-degradates | Rt /min | theoretical [M+H]+ | observed [M+H]+ | fragments |
Azithromycin | 192 | 0.5 | 192.123 | 192.126 | - |
591 | 4.8 | 591.422 | 591.427 | 434.315; 296.217 |
|
434 | 5.2 | 434.312 | 434.315 | - | |
735 | 5.4 | 735.500 | 735.506 | 591.426; 368.257 |
|
592 | 8.5 | 592.406 | 592.408 | 300.278; 237.102 |
|
720 | 8.8 | 720.453 | 720.462 | 540.308; 375.266; 250.994 |
|
Erythromycin | 192 | 0.6 | 192.123 | 192.123 | - |
720 | 7.5 | 720.452 | 720.457 | 558.366; 460.414; 375.263 |
|
Spiramycin | 160 | 0.6 | 160.133 | 160.134 | 142.123 |
322 | 3.2 | 322.186 | 322,185 | 118.086 | |
336 a | 3.7 | 336.202 | 336.204 | 192.122; 174.111; 145.084; 127.074; 101.059 |
|
336 b | 4.4 | 336.202 | 336.204 | 192.122; 174.111; 145.084; 127.074; 101.059 |
|
Tylosin | 192 | 1.1 | 192.123 | 192.123 | - |
215 | 1.8 | 215.128 | 215.090 | - | |
352 | 3.7 | 352.196 | - | ||
336 | 4.2 | 336.202 | 336.201 | - |
compound | MIC against B. subtilis /µg mL–1 | MIC against Ps. fluorescens /µg mL–1 | Daphnia magna LC50 (48 h) mg/La | Fathead minnow LC50 (96 h) mg/La | Fathead minnow LC50 (96 h) mg/Lb, c | Branchiopoda LC50 (48 h) mg/Lb, d |
Azi A | 5.90 | 49.48 | 80.84 | 0.33 | - | 3.04 |
Azi B | 72.43 | 0.87 | - | 2.22 | ||
735 | 98.37 | 0.14 | - | 3.99 | ||
720 | 202.02 | - | - | 28.4 | ||
592 | 108.58 | 0.04 | - | 23.4 | ||
591 | 151.56 | 0.10 | - | 3.26 | ||
434 | 97.23 | 4.09 | 695 | 23.3 | ||
192 | 2067.67 | 4087.53 | 1.58E5 | 1780 | ||
Ery A | 0.21 | 96.90 | 135.5 | - | - | 8.6 |
Ery B | 127.65 | - | - | 0.98 | ||
Ery C | 193.84 | - | 340 | 11.3 | ||
Ery F | 333.08 | - | - | 68.4 | ||
716 | 129.61 | - | 193 | 6.36 | ||
192 | 2067.67 | 4087.53 | 1.58E5 | 1780 | ||
Spi I | 7.03 | 177.75 | 69.14 | - | - | 97 |
Spi Ⅲ | 15.00 | - | - | 34.2 | ||
336 | 579.58 | 410.60 | 2.69E5 | - | ||
322 | 666.63 | 547.26 | 4E5 | - | ||
160 | 367.72 | 1062.61 | 1.88E4 | - | ||
702 | 211.54 | - | - | 703 | ||
Tyl A | 1.26 | 160.80 | 104.55 | - | - | 426 |
Tyl B | 76.56 | - | - | 264 | ||
352 | 347.51 | 683.37 | 4.39E4 | - | ||
336 | 579.58 | 410.60 | 2.69E5 | - | ||
215 | 90.11 | 246.51 | 551 | - | ||
192 | 2067.67 | 4087.53 | 1.58E5 | 1780 | ||
a T.E.S.T b QSAR Toolbox c Pimephales promelas d undefined testorganisms |
Substance | k /min–1 | MIC /µg·mL–1 | tTOX /min |
Azi A | 0.39 | 5.9 | 3.13 |
Azi B | 0.31 | 3.94 | |
Ery A | 0.59 | 0.21 | 7.72 |
Ery B | 0.66 | 6.90 | |
Ery A–H2Oa | 0.59 | 7.72 | |
Ery A–H2Ob | 1.11 | 4.10 | |
Spi I | 0.62 | 7.03 | 1.69 |
Spi Ⅲ | 0.64 | 1.63 | |
Tyl A | 2.47 | 1.26 | 1.12 |
Tyl B | 1.66 | 1.67 |
Irradiation time /min | MIC against B. subtilis /mg L–1 |
0 | 1.05 |
1 | 2.1 |
2.5 | 4.2 |
3.5 | > 8.41 |
5 | > 8.41 |
7 | > 8.41 |